The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

When most people think about bleeding, they imagine visible wounds and blood-stained bandages. However, internal bleeding poses a far more dangerous threat precisely because it often goes ...

Children with hemophilia often didn't make it to adulthood, since a bump or fall could cause massive internal bleeding. But why was hemophilia known as the royal disease? In the 19th century ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

Columnist Alliah Czarielle doesn't want a person with an invisible disability to be perceived by businesses as a fraud.

for the routine prophylaxis of bleeding episodes in patients 12 years of age and older weighing at least 35 kg with severe hemophilia A (congenital factor VIII [FVIII] deficiency, FVIII <1% ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.

Clopidogrel is a prescription drug used to reduce the risk of heart attack and stroke. Learn about the common, mild, and ...